Ray, Makes not mutch difference to some but most US investors do not like penny stocks, smart investors look at the cap rate $192 million for PRR and assess potential of the entire company for $192 million , that is a lot less than Dendreon, was up to over $5 billion, now about $1.2 billion with one product but FDA aproved, the more success PRR has the higher the market will value it, it would be better if it were higher but it is where it is now, Cheers.
doldrums or squally weather??, page-22
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.060(20.3%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 33.5¢ | $6.427M | 18.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 133736 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |